Summary
Thermo Fisher Scientific Inc. (TMO) filed its 2008 annual report on Form 10-K on February 26, 2009, detailing its operations for the fiscal year ending December 30, 2008. The company, formed by the merger of Thermo Electron and Fisher Scientific in November 2006, operates globally as a leader in serving science, offering analytical instruments, equipment, reagents, consumables, software, and services. The report highlights the company's significant revenue growth driven by both organic demand and strategic acquisitions, alongside its operational structure divided into two primary segments: Analytical Technologies and Laboratory Products and Services. Despite a challenging global economic environment at the end of 2008, Thermo Fisher demonstrated resilience, with consolidated revenues increasing by 8% year-over-year. The company emphasizes its commitment to innovation and customer productivity through its diverse product portfolio and extensive sales and service network. Key financial metrics indicate solid performance, with notable increases in operating income and margins, supported by integration savings and productivity improvements. The report also touches upon the company's financial condition, including its debt levels and liquidity, and outlines its strategic priorities moving forward, including continued investment in R&D and potential future acquisitions.
Financial Highlights
54 data points| Revenue | $10.50B |
| Cost of Revenue | $5.30B |
| Gross Profit | $5.20B |
| SG&A Expenses | $2.69B |
| Operating Expenses | $9.27B |
| Operating Income | $1.23B |
| Interest Expense | $151.50M |
| Net Income | $980.90M |
| EPS (Basic) | $2.34 |
| EPS (Diluted) | $2.25 |
| Shares Outstanding (Basic) | 418.20M |
| Shares Outstanding (Diluted) | 434.70M |
Key Highlights
- 1Consolidated revenues reached $10.50 billion in 2008, an 8% increase from $9.75 billion in 2007, driven by increased demand and strategic acquisitions.
- 2The company operates through two main segments: Analytical Technologies, which generated $4.47 billion in revenue, and Laboratory Products and Services, which generated $6.45 billion in revenue.
- 3Operating income increased by 26% to $1.23 billion in 2008 from $974 million in 2007, with operating income margins improving from 10.0% to 11.7%.
- 4Thermo Fisher demonstrated strong operational cash flow, generating $1.42 billion in 2008, underscoring its financial stability.
- 5The company continued its share repurchase program, authorizing up to $500 million in stock repurchases in September 2008, with $414.7 million available at year-end.
- 6Despite global economic uncertainties, the company maintained sufficient liquidity and borrowing capacity, believing it could meet cash requirements for at least the next 24 months.
- 7Research and Development spending was $249 million in 2008, reflecting continued investment in innovation and new product development.